|4Feb 2, 9:46 PM ET

Granfield Christine 4

4 · LEAP THERAPEUTICS, INC. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-01-31
Granfield Christine
VP, Head of Reg Affairs/Qual
Transactions
  • Award

    Restricted Stock Units

    2022-01-31+225,000225,000 total
    Exercise: $0.00Common Stock (225,000 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units were awarded pursuant to Leap's 2016 Equity Incentive Plan for no consideration. Restricted Stock Units will be settled in common stock.
  • [F2]The Restricted Stock Units will cliff vest and be settled after three years of continuous service or upon a change of control of Leap, whichever is earlier.

Documents

1 file
  • 4
    tm225302-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT